Pilulka Lékárny Past Earnings Performance
Past criteria checks 0/6
Pilulka Lékárny's earnings have been declining at an average annual rate of -154.7%, while the Consumer Retailing industry saw earnings growing at 12.7% annually. Revenues have been growing at an average rate of 2.8% per year.
Key information
-154.7%
Earnings growth rate
n/a
EPS growth rate
| Consumer Retailing Industry Growth | 12.4% |
| Revenue growth rate | 2.8% |
| Return on equity | -47.3% |
| Net Margin | -2.7% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Pilulka Lékárny makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 2,447 | -65 | 0 | 0 |
| 31 Dec 21 | 2,380 | -25 | 0 | 0 |
Quality Earnings: PINK is currently unprofitable.
Growing Profit Margin: PINK is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if PINK's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare PINK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PINK is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (13.9%).
Return on Equity
High ROE: PINK has a negative Return on Equity (-47.33%), as it is currently unprofitable.